Paradigm Capital downgraded Nordion NDZ from Buy to Hold and lowered the price target from $9.50 to $8.00.
Paradigm Capital commented, "While the Q4 results were better than expected, we are reducing our price target and downgrading our recommendation to Hold (from Buy), as we believe the company's guidance indicates the business is likely to have a difficult few years ahead. Contributing to this updated view are: 1) escalating internal investigation costs and an increased SG&A requirement to guard against similar issues in the future; 2i) increasing pension costs; 3) lower profitability from Therasphere."
Nordion closed at $6.83 on Monday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in